Craniospinal hyper-or hypotension leads to morphologic changes in certain intracranial structures. We tested the hypothesis that the amount of CSF in the ONS visible in MR imaging is reduced in patients with CSH.
C
SH (also intracranial hypotension) is the result of CSF volume depletion, either due to dural rupture (spontaneous, traumatic, or iatrogenic) or CSF overdrainage in the case of VP shunt surgery. [1] [2] [3] [4] [5] Patients typically complain of orthostatic headaches accompanied by various symptoms, such as neck stiffness, tinnitus, hearing impairment, photophobia, or nausea. 6 In a substantial minority of patients, however, headaches are not orthostatic and may mimic other types of headaches. Some patients with CSH do not have headaches but display various neurologic symptoms. CSF opening pressure during LP is typically decreased in patients with CSH but can also be within the normal range. 4 An LP itself-despite being regarded as the diagnostic criterion standard-can cause CSH and is, therefore, not an ideal diagnostic procedure and should be avoided in these patients.
Neuroimaging supports the diagnosis of CSH, either by directly demonstrating a causative spinal CSF leak or by showing indirect signs of decreased intracranial or intraspinal pressure. Several MR imaging signs associated with CSH have been described, including engorged venous sinuses, narrow ventricles, enhanced meninges, enlarged pituitary gland, subdural effusions, and sagging of the brain. 1, [7] [8] [9] [10] [11] [12] A drawback of these signs is their lack of sensitivity, specificity, and/or objectivity. For example, the presence of engorged venous sinuses seems to be a sensitive sign indicative of CSH, 8, 10 but its evaluation is highly subjective because of normal interindividual variations. Similar problems are encountered when assessing the shape of the ventricles. 3 Meningeal enhancement is also a nonspecific finding in patients with headaches caused by meningitis 1,2 and can be lacking in patients with CSH. 11 Furthermore, contrast agent is not always used in the diagnostic imaging of patients with headache, which limits the usefulness of this sign. An enlarged pituitary gland has been associated with CSH, 7 but age-and sex-dependent variations in the size of the pituitary gland must be taken into consideration. 13 Furthermore, the pituitary gland can also be enlarged in cases of hyperplasia or adenoma. Subdural effusion and sagging of the brain can be caused by CSH, 5, 9 but the opposite is also frequently found: Subdural effusion can cause intracranial hypertension with subsequent sagging of the brain.
Due to the lack of specific clinical symptoms and neuroimaging signs, patients with CSH often are misdiagnosed and erroneously treated for other causes. Thus, CSH was only diagnosed correctly after multiple clinical examinations in 94% of the patients in a former study. 14 The correct diagnosis of CSH-ideally accomplished by noninvasive methods-would not only help to avoid unnecessary risks but would also lead to effective treatment, such as a spinal peridural blood patch. 6 The above-mentioned problems emphasize the need for a simple and reliable parameter for the diagnosis of CSH. Previous studies have shown that the diameter of the ONS might be a sensitive parameter for detection of patients with intracranial hypertension. 15 In this condition, elevated intracranial CSF pressure leads to CSF inflow into the ISSON and subsequently to enlargement of the diameter of the ONS (ONS hydrops). In our experience, the opposite can be demonstrated in patients with CSH. These patients display abnormally little or even no CSF rim in the ONS, and this could be used as a sign of CSH. The aim of this study was to assess the reliability of this sign in patients with CSH by comparing their measurements of the ONS with the measurements in a healthy control population.
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Materials and Methods
Patients
We prospectively included 19 patients admitted consecutively to our departments of neurology and neurosurgery (7 men, 12 women; age range, 18 -72 years; median age, 40 years; Table 1 ) who met the clinical diagnostic criteria of CSH according to the Headache Classification Subcommittee of the International Headache Society (Table 2) . 6 Five patients developed headache within 5 days after LP. In 7 patients, symptoms occurred spontaneously. In another 7 patients, symptoms developed after insertion of a VP shunt. CSF opening pressure during LP was measured in 6 patients in whom CSF analysis or myelography was indicated. It was low-to-normal in 1 patient (11 cm H 2 O, patient 2) and decreased in 5 patients. Exclusion criteria were the usual contraindications for MR imaging.
In all patients, cranial MR imaging was performed for clinical reasons. Nevertheless, written informed consent was obtained, including consent to add MR imaging sequences. Institutional review board approval was also obtained. All patients underwent a standardized cranial MR imaging between February 2006 and February 2009, according to the protocol mentioned below. None of the patients had contraindications (claustrophobia, cardiac pacemakers, or other metallic implants). In all 5 patients with post-LP syndrome, headache resolved with conservative treatment (bedrest, intravenous infusion of half-isotonic sodium chloride solution, and theophylline administration). The same treatment was effective in 3 of the 7 patients with spontaneous CSH. In the remaining 4 patients with spontaneous CSH, peridural spinal blood patches were required. In none of the 7 patients with overdrainage of the VP shunt were headaches severe. Therefore, shunt revisions were not indicated, but headaches did resolve after adjustment of a shunt valve in 1 patient.
Controls
The results of measurements of the ONS in 123 individuals without intracranial hypo-or hypertension, by using identical soft-and hardware, MR imaging protocols, and neuroradiologic readers, were used for comparison. Results of our control group have previously been published. 13 Because no correlations of the ONS diameters with sex or age were found in this study, patients and controls were not matched for these characteristics.
MR Imaging
Cranial MR imaging was performed in all individuals on a 3T scanner (Achieva, Philips Healthcare, Best, the Netherlands; SENSE Head coil, 8 elements, Philips Healthcare) by using a standardized protocol that included at least the following sequences: T2WI TSE, axial (TR/TE, 4456/100 ms; section thickness, 3 mm), MRV (TR/TE, 18/6.5 ms; section thickness, 0.8 mm; velocity encoding, 12 cm/s), STIR (TR/TE/TI, 3709/80/200 ms; section thickness, 3 mm) covering the orbit and the pituitary gland in the coronal plane, sagittal FLAIR (TR/TE/TI, 12000/160/2850 ms; section thickness, 3 mm), and T1WI axial GRE (TR/TE, 319/22.3 ms; section thickness, 4 mm). In 12 patients, contrast-enhanced T1WI GRE sequences were also performed.
MR Image Analysis
The vertical diameter of the ONS-including the CSF rim in the ISSON-and the vertical diameter of the optic nerve without the CSF rim were measured at 4 intraorbital positions (3, 6, 10, and 20 mm behind the eyeball; Fig 1) . The width of the ISSON was assessed by subtraction of both measurements and subsequent division by 2. The intraorbital positions were specified by cross-referencing on axial T2WIs. Because there was no difference in the diameters between the left and right ONS, only the left ONS of patients was chosen for analysis (1 measurement at each position). A pathologic diameter was defined as any value below the third percentile of the normal range (1.0 mm in position 1, and 0.9 mm in positions 2-4). If a CSF rim around the optic nerve was not visible, the ISSON was defined as "collapsed." Irrespective of the quantitative measurements, readers were asked to visually judge whether the ISSON width in patients was pathologically narrow or collapsed along its entire course during a second reading (visual inspection). In all patients, the height of the pituitary gland was measured on coronal STIR images and was compared with previously published sex-and age-adjusted normal values (maximum normal pituitary gland height: 5.6 mm [men], 6.9 mm [women 16 -40 years of age], 5.8 mm [women 41-62 years of age], and 6.0 mm [women Ͼ62 years of age]). 13 We also subjectively assessed the presence of venous sinus engorgement in maximum intensity projections of MRV, the presence of narrow ventricles in T2WIs, the presence of meningeal enhancement in patients who received contrast-enhanced T1WIs, the presence of subdural effusions, and the presence of brain sagging in FLAIR images of our patient population. All measurements were analyzed by 3 readers: 1) A.R., experienced board-certified radiologist and neuroradiologist; 2) U.J., Specialist Registrar in neuroradiology, 3) M.-C.F., senior medical student who was trained to perform measurements of the ONS on MR imaging. The results of the first reader were used for the primary analysis. The results of all 3 readers were used to calculate interobserver reliabilities.
Statistics
Images were randomly assigned to the 3 readers, and data were stored on Excel spreadsheets (Microsoft, Bothell, Washington). Statistical analysis was done by using the software tools Statistical Package for the Social Sciences, Version 15 (SPSS, Chicago, Illinois) and R package, Release 2.11.0 (open source software, The R Foundation for Statistical Computing, Vienna, Austria). The Mann-Whitney U test was used to prove differences between values of measurements in patients with CSH and controls. The diagnostic sensitivity (including 95% CIs) was assessed to compare the results of ONS measurements and different MR imaging signs of CSH. In individuals with collapsed ISSONs, the width of the ISSON was defined as zero in the statistical analysis. To determine the degree of interobserver reliability in visual interpretation of nonquantitative features of CSH (engorgement of venous sinuses, narrow ventricles, dural enhancement, subdural effusion, brain sagging, and narrow or collapsed ISSON), we calculated values. Likewise, the ICC was computed to determine the degree of the interobserver reliability for the quantitative values (width of the ISSON and height of the pituitary gland).
Results
The ISSON widths of patients differed significantly from those of controls as a result of diminished CSF. Values of measurements are listed in Table 3 . Collapsed ISSON was observed with a sensitivity of 44% in position 1 (3 mm behind the eyeball), 74% in position 2 (6 mm behind the eyeball), 74% in position 3 (10 mm behind the eyeball), and 84% in position 4 (20 mm behind the eyeball); it was not observed in any patient from the control population (specificity, 100%). A reduction in the ISSON width below normal limits or a collapsed ISSON was detected with sensitivities of 61%, 84%, 100%, and 100% in positions 1-4, respectively. Specificity was 97% for each position. In 8/19 patients (42%) with CSH, the ISSON was collapsed along its entire length. In the remaining 11 patients (58%), we found only residual CSF signal intensity predominantly in the most frontal part of the ISSON. On visual interpretation, all 3 readers agreed that the width of the ISSON was abnormally narrow or that the ISSON was entirely collapsed in all patients.
The height of the pituitary gland was significantly larger in symptomatic patients (6.9 Ϯ 2.3 mm) than in the control population (4.3 Ϯ 0.9 mm, P ϭ .001). It was above the normal limit in 12 of 19 patients (sensitivity, 63%; specificity, 97%; Table 4 ). An example of a "collapsed ONS" and enlargement of the pituitary gland in a patient with CSH and follow-up imaging after treatment is shown in Fig 2. Descriptive imaging features of CSH were recorded but were not matched with a control group. Frequencies for these features were 84% for venous sinus engorgement, 79% for dural enhancement, 68% for subdural effusion, 47% for narrow ventricles, and 32% for brain sagging (Table 4) . At least 1 of these features was present in 17 of 19 patients (89%).
The interobserver reliability was high regarding measurements of the pituitary gland height (ICC ϭ 0.974). It was also high regarding measurements of the ISSON width, with the ICC being better in the anterior aspect (ICC ϭ 0.908 in position 1) than in the posterior aspect of the ONS (ICC ϭ 0.824 in position 4). The interobserver reliabilities regarding nonquantitative features of CSH were best for the features "presence of subdural hygromas" and "presence of abnormally narrow ISSON" ( ϭ 1.0 each) and worst for the feature "presence of narrow ventricles" ( ϭ 0.579, Tables 3 and 4) .
The number of patients was too small to allow a meaningful statistical analysis of patient subgroups. There seems to be a tendency for our patients with post-LP syndrome to exhibit some features less often than patients with idiopathic CSH or patients with overdrainage of a VP shunt (narrow ventricles [20% versus Follow-up MR images were available in 6 patients. Two of those patients with idiopathic CSH received epidural blood Frequency  63%  84%  47%  79%  68%  32%  95% CI  38%-84%  60%-97%  24%-71%  49%-95%  43%-87%  13%- patches. Follow-up MR imaging showed normalization of the ONS in both patients (Fig 2) . In another 2 patients who received epidural blood patches, headaches resolved but follow-up MR images were not available. Normalization of the ONS was also documented with MR imaging in 1 patient with post-LP syndrome (Fig 3) . In 1 patient with a VP shunt, ONS normalized on follow-up MR imaging after valve adjustment. The ONS of 2 patients with shunts whose valves could not be changed remained pathologic on follow-up. The clinical features of these patients did not change. 
Discussion
In the present study, we tested the hypothesis that the width of the ISSON is reduced in patients with CSH due to a lack of normal CSF accumulation. The normal width of the CSF rim in the ISSON as measured by cranial MR imaging in our control population ranges from 1.4 Ϯ 0.3 mm (anterior) to 1.0 Ϯ 0.2 mm (posterior). 13 According to the Monro-Kellie hypothesis, CSF hypovolemia caused by spinal CSF leakage results in lower intracranial pressure so that the intracranial/extracranial pressure gradient is reduced or nonexistent. 3 As a result, CSF outside the cranial space (ie, in the orbit) should be expected to be diminished in CSH. We observed this phenomenon in all our patients with CSH. CSF in the ISSON was either reduced (predominantly in the anterior aspects of the ONS) or it was absent (predominantly in the posterior aspects of the ONS). Taking into account a lower normal cutoff value of 0.9 mm for the width of ISSON, we could predict CSH with a sensitivity of 100% and a specificity of 97% in our patient population when the middle and dorsal positions (positions 3 and 4) were evaluated.
A more subjective approach of visually judging a reduction in the amount of CSF or lack of CSF in the ISSON in patients with CSH has its practical merits as well: There was excellent agreement among our 3 readers, all experienced in orbital imaging, that the amount of CSF was pathologically reduced or absent in all patients of our cohort. Our findings are in accordance with a case series of 3 patients with CSH in whom decreased ONS diameters were reported. 16 In that publication, however, a different MR imaging technique was used (fatsaturated T2WIs with a 1.5T magnet) and the total ONS diameters were measured at only 1 position just behind the eyeball. Our study shows that measuring the CSF rim in the ISSON at that position can lead to false-negative results.
In our opinion, the sign of the collapsed ISSON has advantages in comparison with other reported MR imaging signs of CSH: It is sensitive and, because normal limits of the width of the ONS are known, less subjective. Enlargement of the pituitary gland in patients with CSH-the second sign we assessed quantitatively-was observed with a sensitivity of 63% and a specificity of 97% by using age-and sex-adjusted normal cutoff values. Because the main differential diagnosis, namely pituitary hyperplasia, is rare, we believe that this sign is also very useful in the work-up of patients with suspected CSH. The etiology of this enlargement, however, is not fully understood. We assume that edema with consecutive enlargement of the pituitary gland could result from low or negative pressure in the sella turcica.
Recently, it has been reported that distended epidural veins and epidural fluid accumulation detected in spinal MR imaging might be more sensitive in the diagnosis of CSH than cranial MR imaging, with reported sensitivities of 95% versus 83%, respectively. 17 Our results indicate that cranial MR imaging can be even more sensitive than spinal MR imaging when high-contrast and high-resolution orbital imaging is applied. The STIR sequence perpendicular to the optic nerve used in our protocol (duration of 3 minutes 35 seconds) can be easily included in routine cranial MR imaging scans. Because it allows measurement of both the ONS diameter and the height of the pituitary gland, this sequence can be used to deliver 2 important parameters for the diagnosis of CSH.
Conclusions
In patients with CSH, CSF content in the ISSONs is absent or reduced to below a width of 0.9 mm on coronal 3T images (collapse of the ONS). This phenomenon lends itself well to visual interpretation on fat-suppressed sequences and can be regarded as a new sign of CSH. Our data suggest that the sensitivity and specificity of this sign might be higher than that of other known features. Including orbital imaging in the work-up of patients with CSH might, therefore, increase the accuracy of the diagnosis.
